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Edited by Horst FeldmannAbstract In the mouse macrophage-like cell line RAW 264,
vacuolar-type (H+)-ATPase (V-ATPase) inhibitors, baﬁlomycin
A1 and concanamycin A, increased the level of cyclooxygenase
(COX)-2 protein and its mRNA. The V-ATPase inhibitor-
induced expression of COX-2 was suppressed by inhibitors of
c-jun N-terminal kinase (JNK) and nuclear factor-jB, and by
inhibitors of Na+/H+ exchangers (NHEs). The baﬁlomycin
A1-induced activation of JNK but not degradation of IjB-a
was suppressed by NHE inhibitors and by an inhibitor of Na+/
Ca2+ exchanger SN-6. These results suggested that V-ATPase
inhibitors induce the expression of COX-2 via NHE-dependent
and -independent pathways.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Vacuolar-type (H+)-ATPase (V-ATPase), which transports
proton from the cytoplasmic compartment to the opposite side
of the membrane, is mainly present in cytoplasmic vesicle
membranes, and is involved in endocytosis and hydrolysis in
lysosomes, intracellular membrane transport, and cytoplasmic
pH homeostasis [1]. V-ATPases have also been identiﬁed in the
plasma membrane of macrophages, osteoclasts, and cancer
cells. In macrophages, the V-ATPase in plasma membrane is
involved in cytoplasmic pH homeostasis. However, in osteo-Abbreviations: COX, cyclooxygenase; DMA, 5-(N,N-dimethyl)-amilo-
ride; EIPA, 5-(N-ethyl-N-isopropyl)-amiloride; GAPDH, glyceralde-
hyde 3-phosphate dehydrogenase; IjB, inhibitor of jB; iNOS,
inducible nitric oxide synthase; JNK, c-jun N-terminal kinase; LPS,
lipopolysaccharide; NCX, Na+/Ca2+ exchanger; NF-jB, nuclear fac-
tor-jB; NHE, Na+/H+ exchanger; PG, prostaglandin; PBS, phosphate-
buﬀered saline; RT-PCR, reverse transcription-polymerase chain
reaction; V-ATPase, vacuolar-type (H+)-ATPase
*Corresponding author. Fax: +81 22 795 6863.
E-mail address: hirasawa@mail.pharm.tohoku.ac.jp (N. Hirasawa).
0014-5793/$32.00  2007 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2007.08.055clasts, it contributes to the eﬄux of intracellular proton, which
promotes loss of bone matrix in patients with rheuma-
toid arthritis and osteoporosis [2,3]. Furthermore, V-ATPases
have been proposed to have a role in tumor metastasis.
Tumor cells degrade the extracellular matrix for metastatic
invasion via lysosomal enzymes, which are active in acidic
environments. In addition to metastasis, V-ATPase is also
involved in the growth and multidrug-resistance of cancer
cells [4].
Thus, inhibitors of V-ATPase are expected to become ther-
apeutic agents for several bone diseases and cancer [1]. How-
ever, the treatment of mouse peritoneal macrophages with
the V-ATPase inhibitor baﬁlomycin A1 induced the produc-
tion of inﬂammatory cytokines including tumor necrosis fac-
tor-a, interferon-c, and interleukin-6 [5]. We also revealed
that baﬁlomycin A1 increased the production of nitrite oxide
by inducing expression of the inducible nitric oxide synthase
(iNOS) [6]. Thus, the inhibition of V-ATPase causes the activa-
tion of intracellular signaling pathways. However, the molecu-
lar mechanism by which V-ATPase inhibitors induce the
expression of inﬂammatory proteins still remains to be clari-
ﬁed.
Na+/H+ exchangers (NHEs) are also transmembrane pro-
teins and regulate cytoplasmic pH [7]. We have reported that
inhibitors of NHEs suppressed the expression of COX-2 in
the macrophage-like cell line RAW 264 stimulated by lipopoly-
saccharide (LPS) [8]. A V-ATPase inhibitor caused a reduction
of cytoplasmic pH, resulting in the activation of NHEs to
maintain the cytoplasmic pH in human myelomonocytic
U937 cells [9]. Therefore, we examined whether NHEs are
involved in the V-ATPase-induced activation of macrophages.
In this study, we revealed that V-ATPase inhibitors induced
the expression of cyclooxygenase (COX)-2, a key enzyme in
the production of PGs in macrophages, and that the eﬀect
was blocked by NHE inhibitors.2. Materials and methods
2.1. Reagents
Baﬁlomycin A1, concanamycin A, and lipopolysaccharide were pur-
chased from Wako Pure Chemicals (Osaka, Japan). Amiloride (3,5-
diamino-6-chloro-N-(diaminomethylidene)pyrazine-2-carboxamide
hydrochloride), 5-(N,N-dimethyl)-amiloride (DMA), and 5-(N-ethyl-
N-isopropyl)-amiloride (EIPA) were obtained from Sigma–Aldrichblished by Elsevier B.V. All rights reserved.
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(Kobe, Japan). SP600125 and Bay 11-7082 were purchased from Cal-
biochem (Darmstadt, Germany).2.2. Cell culture
RAW 264, a mouse macrophage cell line, was obtained from Riken
Gene Bank (Tsukuba, Japan) and cultured at 37 C under 5% CO2–
95% air in Eagle’s minimal essential medium (Nissui Pharmaceutical,
Tokyo, Japan) containing 10% (v/v) fetal bovine serum (Sigma-
Aldrich), penicillin G potassium (15 lg/ml), and streptomycin sulfate
(50 lg/ml) (Meiji Seika, Tokyo, Japan). RAW 264 cells were suspended
at 5.0 · 105 cells/ml in the same medium, and 1.0 ml of the cell suspen-
sion was seeded in each well of a 12-well cluster dish (Greiner BioOne
GmbH, Frickenhausen, Germany).
2.3. Drug treatment
The V-ATPase inhibitors (baﬁlomycin A1 and concanamycin A),
NHE inhibitors (DMA and EIPA), SP600125, Bay 11-7082, and SN-
6 were dissolved in DMSO. Amiloride and LPS were dissolved in auto-
claved water, and diluted with the medium. RAW 264 cells (5.0 · 105)
were incubated for 20 h at 37 C in 1 ml of medium. The cells were then
washed three times with PBS and further incubated at 37 C for theCOX-2
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Fig. 1. Eﬀects of baﬁlomycin A1 on the expression of COX-2. RAW 264 cel
cells were then washed three times with PBS, and further incubated at 3
baﬁlomycin A1 (A, B, and C) or LPS (A) for the indicated periods (A), 12 h (
determined by Western blotting (A and B) and a densitometric analysis (B).
non-stimulated control is set to 1.0. (C) Levels of mRNA for COX-2 and GA
density ratio of COX-2 to GAPDH was calculated and its value in the non-periods indicated in 1 ml of medium containing baﬁlomycin A1
(100 nM), concanamycin A (100 nM), or LPS (0.1 lg/ml) with or with-
out various concentrations of the NHE inhibitors. Final concentration
of DMSO was adjusted to be 0.2% (v/v).
2.4. Western blot analysis
After the incubation, the cells were washed three times with PBS,
and lysed in 90 ll of ice-cold lysis buﬀer (20 mM HEPES, pH 7.4,
1% (v/v) Triton-X 100, 10% (v/v) glycerol, 50 mM sodium ﬂuoride,
2.5 mM p-nitrophenyl phosphate, 10 lg/ml phenylmethylsulfonyl ﬂuo-
ride, 1 mM Na3VO4, 10 lg/ml leupeptin, and 1 mM EDTA). The pro-
teins in the cell lysates were separated by SDS–PAGE and transferred
electrophoretically onto a polyvinyliden diﬂuoride membrane (Amer-
sham Biosciences, Buckinghamshire, England). COX-2, inhibitor of
jB (IjB)-a, and actin were detected by immunoblotting using poly-
clonal antibodies for COX-2, IjB-a, and actin (Santa Cruz Biotechnol-
ogy Inc., Santa Cruz, CA, USA), respectively. The phosphorylation of
c-jun N-terminal kinase (JNK) was detected using polyclonal antibod-
ies for phospho-JNK (Thr183/Tyr185) (Santa Cruz). The proteins were
detected by using a chemiluminescence detection system (ECL system,
PerkinElmer Life Sciences, Boston, MA, USA). The protein levels of
COX-2 and actin were quantiﬁed by scanning densitometry, and sub-
jected to statistical analysis.0
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Fig. 2. Eﬀects of SP600125 and Bay 11-7082 on the baﬁlomycin A1-
induced increase in the level of COX-2 mRNA. RAW 264 cells
(5.0 · 105) were incubated at 37 C for 20 h in 1 ml of medium. The
cells were then washed three times with PBS, and further incubated at
37 C for 8 h in 1 ml of medium containing baﬁlomycin A1 (100 nM)
F. Kamachi et al. / FEBS Letters 581 (2007) 4633–4638 46352.5. Reverse transcription (RT)-polymerase chain reaction (PCR) for
COX-2 mRNA
After the incubation, the cells were washed three times with PBS and
total RNA was extracted using a GenEluteMammalian Total RNA
Kit (Sigma-Aldrich) according to the manufacturer’s instructions. The
extracted RNA (1 lg) was reverse-transcribed at 37 C for 1 h in 20 ll
of a solution containing 5 lM of random hexamer oligonucleotides
(Gibco BRL, Rockville, MD, USA), 200 U of reverse transcriptase
(Takara Bio Inc., Shiga, Japan), 0.5 mM deoxyribonucleotide triphos-
phates (Takara), and 10 mM dithiothreitol (Takara). The PCR primers
for mouse COX-2 were 5 0-TTG AAG ACC AGG AGT ACA GC-3 0
(former) and 5 0-GGT ACA GTT CCA TGA CAT CG-3 0 (reverse).
PCR was performed for 27 cycles; 0.5 min of denaturation at 94 C,
0.5 min of annealing at 52C, and 0.5 min of extension at 72 C using
a DNA thermal cycler (Takara). The PCR primers for mouse glyceral-
dehyde 3-phosphate dehydrogenase (GAPDH) were 5 0-TGA TGA
CAT CAA GAA GGT GGT GGA-3 0 (former) and 5 0-TCC TTG
GAG GCC ATG TAG GCC AT-3 0 (reverse). PCR was performed
for 24 cycles; 0.5 min of denaturation at 94 C, 1 min of annealing at
57 C, and 2 min of extension at 72 C. After PCR, 10 ll of the reac-
tion mixture was subjected to electrophoresis on a 1.5% agarose gel,
and the PCR products were visualized by ethidium bromide staining.
2.6. Statistical analysis
Values in the ﬁgures are expressed as means from three or four sam-
ples with the S.E.M. shown by vertical bars. Results were analyzed for
statistical signiﬁcance using Student’s t-test for unpaired observations.with or without SP600125 (10 lM) or Bay 11-7082 (10 lM). Levels of
mRNA for COX-2 and GAPDH were determined by RT-PCR and a
densitometric analysis. The density ratio of COX-2 to GAPDH was
calculated and its value in the baﬁlomycin A1 control is set to 1.0.
Statistical signiﬁcance: *P < 0.05 vs. non-stimulated control,
###P < 0.001 vs. baﬁlomycin A1 control.3. Results
3.1. Eﬀects of baﬁlomycin A1 on the COX-2 expression
In unstimulated RAW 264 cells, COX-2 protein was almost
not detected during the experimental periods (Fig. 1A). On
treatment of the cells with baﬁlomycin A1 (100 nM), the level
of COX-2 protein increased from 8 h, attained a maximum
at 12 h, and then declined to 24 h (Fig. 1A). The time change
was transient and slow as compared with that of LPS
(0.1 lg/ml)-induced expression of COX-2 (Fig. 1A).
The expression of COX-2 protein at 12 h was increased
by baﬁlomycin A1 in a concentration-dependent manner
(Fig. 1B) and correlated to the increase in the level of COX-2
mRNA at 8 h (Fig. 1C).
3.2. Eﬀects of JNK inhibitor SP600125 and nuclear factor (NF)-
jB inhibitor Bay 11-7082 on the baﬁlomycin A1-induced
increase in the level of COX-2 mRNA
We examined the eﬀects of SP600125 and Bay 11-7082 on
the baﬁlomycin A1-induced increase in the level of COX-2
mRNA, because the V-ATPase inhibitors increased iNOS
mRNA level via activating JNK and NF-jB [6]. The baﬁlomy-
cin A1-induced increase in the level of COX-2 mRNA was
almost completely suppressed by SP600125 (10 lM) and Bay
11-7082 (10 lM) (Fig. 2).
3.3. Eﬀects of the NHE inhibitors on the V-ATPase inhibitor-
induced COX-2 expression
To get further insight into the actions of baﬁlomycin A1 on
the COX-2 expression, we examined the eﬀects of the NHE
inhibitors on the baﬁlomycin A1-induced expression of COX-
2. The NHE inhibitor, amiloride (30 and 100 lM), signiﬁcantly
inhibited the baﬁlomycin A1-induced expression of COX-2
protein in a concentration-dependent manner, and the inhibi-
tory eﬀect was more potent than that on the LPS-induced
upregulation of COX-2 protein (Fig. 3A). More selective
NHE inhibitors, DMA (10 lM) and EIPA (3 lM), also inhib-ited the baﬁlomycin A1-induced expression of COX-2 protein
(Fig. 3B). In addition, these NHE inhibitors suppressed the
baﬁlomycin A1-induced increase in the level of COX-2 mRNA
at 8 h (Fig. 3C). To conﬁrm that baﬁlomycin A1 induced the
expression of COX-2 via inhibiting V-ATPase, the eﬀect of
the other V-ATPase inhibitor concanamycin A on the expres-
sion of COX-2 was examined. Concanamycin A (100 nM)
increased expression of COX-2 protein to almost the same
level with that in the baﬁlomycin A1 (100 nM)-stimulated cells,
and the increase was also inhibited by the NHE inhibitors
(Fig. 3D).
3.4. Eﬀects of the NHE inhibitors on the baﬁlomycin A1-induced
phosphorylation of JNK and degradation of IjB-a
The stimulation of RAW 264 cells with baﬁlomycin A1
(100 nM) for 45 min induced the phosphorylation of JNK
and the degradation of IjB-a, the inhibitory protein of NF-
jB (Fig. 4), as previously reported [6]. Amiloride (100 lM),
DMA (10 lM), and EIPA (3 lM) partially inhibited the baﬁlo-
mycin A1-induced phosphorylation of JNK, but failed to pre-
vent the degradation of IjB-a (Fig. 4).
3.5. Eﬀects of the Na+/Ca2+ exchanger (NCX) inhibitor SN-6
on the baﬁlomycin A1-induced COX-2 expression, phosphor-
ylation of JNK and degradation of IjB-a
The increase in intracellular Na+ ions mediated by NHE
may induce the entry of Ca2+ ions by NCX. To clarify the
involvement of NCX in V-ATPase inhibitor-induced expres-
sion of COX-2, the eﬀects of a NCX inhibitor SN-6 [10]
was examined. SN-6 decreased the baﬁlomycin A1-induced
COX-2 expression (Fig. 5A) and phosphorylation of JNK
(Fig. 5B) in a dose-dependent manner, but almost not the deg-
radation of IjB-a (Fig. 5B).
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Fig. 3. Eﬀects of the NHE inhibitors on the V-ATPase inhibitor-induced expression of COX-2. RAW 264 cells (5.0 · 105) were incubated at 37 C for
20 h in 1 ml of medium. The cells were then washed three times with PBS, and further incubated at 37 C for 12 h (A, B, and D) or 8 h (C) in 1 ml of
medium containing baﬁlomycin A1 (100 nM), LPS (0.1 lg/ml) (A), or concanamycin A (D) with or without amiloride (A, C, and D), DMA, or EIPA
(B, C, and D) at the indicated concentrations. (A and B) Protein levels of COX-2 and actin in the cell lysates were determined by Western blotting
and a densitometric analysis. The density ratio of COX-2 to actin was calculated and its value in the baﬁlomycin A1 control is set to 1.0. (C) Levels of
mRNA for COX-2 and GAPDH were determined by RT-PCR, and a densitometric analysis. The density ratio of COX-2 to GAPDH was calculated
and its value in the baﬁlomycin A1 control is set to 1.0. Statistical signiﬁcance: *P < 0.05, **P < 0.01, and ***P < 0.01 vs. non-stimulated control,
#P < 0.05, ##P< 0.01, and ###P < 0.001 vs. baﬁlomycin A1 control. (D) Protein levels of COX-2 and actin in the cell lysates were determined by
Western blotting.
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In this study, we revealed that V-ATPase inhibitors induce
the expression of COX-2 via activating JNK and NF-jB,
and that NHE inhibitors prevent its expression and the activa-
tion of JNK.
V-ATPase inhibitors induce the production of inﬂammatory
cytokines [5] and the expression of iNOS [6] in macrophages.
In this study, we revealed that V-ATPase inhibitors, baﬁlomy-
cin A1 and concanamycin A, induced the expression of COX-
2, a key enzyme of production of PGs in macrophage, too.
PGE2 enhances bone resorption by osteoclasts [11], angiogen-
esis in surrounding tissue of solid tumor [12,13] and tumor
progression [14]. Therefore, although V-ATPase inhibitors
are expected to be a new drug for bone diseases and cancerthrough inhibiting the eﬄux of intracellular proton, the expres-
sion of COX-2 induced by V-ATPase inhibitors might attenu-
ate their putative therapeutic eﬀects through inducing the
production of PGE2. We found that the inhibitors of NHE,
amiloride, DMA and EIPA, prevent the V-ATPase inhibitor-
induced expression of COX-2 (Fig. 3) in addition to LPS-in-
duced one as reported previously [8]. COX inhibitors potently
reduce the production of PGs but sometimes enhance the pro-
duction of cytokines/chemokines [15]. In contrast, NHE inhib-
itors reduce it [16] as well as PGE2 production [8]. Thus, the
inhibitor of NHE might be suitable to reduce the probable
side-eﬀects of V-ATPase inhibitors.
Consisting with our previous report that V-ATPase inhibi-
tors induce the expression of iNOS via activating JNK and
NF-jB [6], baﬁlomycin A1-induced expression of COX-2 was
IκB-α
Actin
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Fig. 4. Eﬀects of the NHE inhibitors on the baﬁlomycin A1-induced
phosphorylation of JNK and degradation of IjB-a. RAW 264 cells
(5.0 · 105) were incubated at 37 C for 20 h in 1 ml of medium. The
cells were then washed three times with PBS, and further incubated at
37 C for 45 min in 1 ml of medium containing baﬁlomycin A1
(100 nM) and the NHE inhibitors at the indicated concentrations.
Phosphorylated JNK, IjB-a, and actin were detected by Western
blotting.
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Fig. 5. Eﬀects of SN-6 on the baﬁlomycin A1-induced expression of
COX-2, phosphorylation of JNK and degradation of IjB-a. RAW 264
cells (5.0 · 105) were incubated at 37 C for 20 h in 1 ml of medium.
The cells were then washed three times with PBS, and further
incubated at 37 C for 12 h (A) or 45 min (B) in 1 ml of medium
containing baﬁlomycin A1 (100 nM) and SN-6 at the indicated
concentrations. COX-2 (A), phosphorylated JNK and IjB-a (B) were
detected by Western blotting.
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promoter of mouse COX-2 gene has a number of regulatory
elements which include a cAMP response element (CRE-2),
NF-jB site and AP-1 site. JNK phosphorylates c-Jun, result-
ing in the activation of AP-1. In addition, phosphorylated
c-Jun also binds to CRE-2 site in COX-2 promoter region
[17]. The ﬁndings that each inhibitor inhibited completely the
COX-2 expression suggest that the binding of both phosphor-
ylated c-Jun and NF-jB was required to activate the transcrip-
tion. Our results are in line with the report of von Kenethen
et al. [18], who demonstrated that the expression of COX-2by oxygen radicals in RAW 264.7 cells is completely inhibited
by NF-jB decoy and by dominant negative c-Jun.
In this study, we found that NHE inhibitors reduced the V-
ATPase inhibitor-induced activation of JNK but not the deg-
radation of IjB-a (Fig. 4), suggesting that the inhibition of
JNK resulted in the decrease in the level of COX-2 mRNA
(Fig. 3). Since amiloride did not inhibit the LPS-induced phos-
phorylation of JNK [8], it was unlikely that amiloride directly
inhibited kinases involving in the activation of JNK. The inhi-
bition of V-ATPase reduces cytosolic pH resulting in the acti-
vation of NHE [9]. The activation of NHE results in the
accumulation of intracellular Na+, which, in turn, increases
intracellular Ca2+ via NCX [19]. Thus, the collaboration of
NCX with NHE might induce activation of JNK. This hypoth-
esis was supported by the ﬁnding that the NCX inhibitor SN-6,
as well as amiloride, inhibited baﬁlomycin A1-induced phos-
phorylation of JNK but not degradation of IjB-a (Fig. 5).
Ca2+-induced increase in the level of COX-2 mRNA was inhib-
ited by JNK inhibitor, but not by NF-jB inhibitor in human
ﬁbroblasts [20]. In contrast, the decrease in intracellular pH in-
duced transactivation of NF-jB [21,22]. Taken together, it was
suggested that V-ATPase inhibitors induced the activation of
JNK via NHE- and NCX-mediated pathway and the activa-
tion of NF-jB via NHE-independent pathway, probably the
decrease in intracellular pH.
V-ATPase inhibitors change the cytoplasmic pH without
activation of receptors on plasma membrane. In contrast,
the stimulation of receptors in inﬂammatory cells with the
ligands such as LPS induces the change of cytoplasmic pH.
In our previous study, NHE inhibitors reduced LPS-induced
increase in the level of COX-2 protein without aﬀecting the
level of COX-2 mRNA, indicating that the changes of cyto-
plasmic pH might aﬀect various steps including the translation
and/or stability of COX-2 protein [8]. However, it remains to
be clariﬁed how the change of cytoplasmic pH aﬀects the sig-
nalings induced by the receptor stimulation. Therefore, the
inhibitors of V-ATPase and NHE are good tools to clarify
the role of the change of cytoplasmic pH in the cell activation.
Our ﬁndings also suggest that NHE play a role as a converter
from the change of intracellular pH to the activation of signal-
ing pathway. Thus, NHE would become a novel target for
developing anti-inﬂammatory drugs inhibiting the activation
of inﬂammatory cells.References
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